Immunocore
Abingdon, Oxon | Gaithersburg, United Kingdom | United States of America
Overview
Company details and contact information.
About
About Immunocore Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy. Our mission is to radically improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases, by pioneering and delivering transformative immunomodulating medicines. Built on our proprietary ImmTAX technology, we have a pipeline of investigational bispecific TCR therapies across a broad range of diseases, including multiple types of cancers, HIV, type 1 diabetes, and other autoimmune diseases. CM-US--2600011
- Website
- https://immunocore.com
- Address
- Immunocore Limited 92 Park Drive, Abingdon, Oxon, OX14 4RY, UK | 9801 Washingtonian Blvd, Suite 800, Gaithersburg MD 20878, United States of America
People
Contacts connected to this company.